Clinical Trial Update: Study With Rituximab, Cyclophosphamide, Doxorubicin Liposomal (Myocet®), Vincristine, Prednisone, (R-COMP) to Treat Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the R-COMP regimen (rituximab, cyclophosphamide, doxorubicin liposomal, vincristine, prednisone) for diffuse large B-cell lymp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin Liposomal (Myocet) (doxorubicin liposomal)
• PREDNISONE (Prednisone)
• Rituximab (rituximab)
• Vincristine (vincristine)

Snippet

Sponsor: Fondazione Italiana Linfomi - ETS | Conditions: Diffuse Large B-Cell Lymphoma | Phase 2 | Status: UNKNOWN